MIT-founded biochemical water treatment company Solugen has increased its funding total to at least $48.7m.

The second quarter total is up from $185m the previous year and $392m quarter-on-quarter despite coronavirus-driven pressures.

Primary care network Oak Street Health has filed for a $100m offering on the New York Stock Exchange that will give Humana an exit.

Memorial Sloan Kettering spinout Paige’s series B total stands at $70m following a third tranche featuring Goldman Sachs and Healthcare Venture Partners.

3B Future Health Fund has participated in the cancer drug developer’s $5.8m extension round, investing alongside returning backers including M Ventures.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

A total of 23 biopharmaceutical producers have committed capital to the vehicle, which will provide funding for the creation of new antibiotics.

Neurodegenerative disease company Transquis has emerged from stealth with $30m in series A funding to advance research conducted at Stanford.

Eir’s first fund will partner Nordics-based universities to invest in their spinouts, while also making selected deals in the rest of Europe and the US.

Novo is among the limited partners for Eir Ventures, which has launched with $86m to invest in life sciences technology startups.